As the only conference dedicated to GBM drug development, this is the go-to event for industry leaders to showcase themselves to an audience of experts from all areas of the glioblastoma landscape. As the space moves towards combination approaches and utilizing next-generation therapeutic modalities, the potential for a breakthrough in GBM treatment is growing.

With the event serving as a forum for sharing up and coming developments as well as key obstacles, it is ideal for identifying gaps in the market that your services can fill.

Why Partner?

• This summit brings together a dedicated coalition of pharma and biotech and academic KOLs sharing first-hand insight into what the market need so that you can provide customized solutions

• The GBM drug development community face unique challenges such as blood brain barrier penetrance that makes them reliant on solution providers like you for drug delivery technologies
• A key challenge with GBM drug development is providing funders with reliable preclinical results, contingent on the use of suitable pre-clinical models. While the community debate what models are most reliable, this is your opportunity to showcase the promise of your models to both funders and drug developers
• Being the only glioblastoma-focussed meeting, this is the go-to meeting for experts in the space providing you the ultimate networking experience with the key decision makers from all areas of glioblastoma research

Please get in touch today to find out how our partnership opportunities can assist you in making valuable connections and generating actionable leads to meet your business goals more quickly, efficiently, and economically. Contact us via sponsor@hansonwade.com.